English

Ratos: Arcus Gruppen concentrates operations

Report this content 

                        
Ratos: Arcus Gruppen concentrates operations Arcus Gruppen is selling its Arcus Kjemi business to the Norwegian company Pemco AS, who owns 100% of Kemetyl Group AS, for an Enterprise Value of NOK 112m. In addition, the sale of a rectification facility in Hamar has been completed. "Arcus Kjemi sells alcohol- and isopropanol-based products for technical and medical activities - something that is not a part of Arcus Gruppen's core business," says Jan Tore Føsund, CEO of Arcus Gruppen. "I am therefore very happy that through today's agreement we have found a new, natural home for the company and its employees." Arcus Kjemi's operations, which are concentrated in Vestby and Halden, just outside Oslo, will have estimated sales of approximately NOK 300m in 2006. Arcus Gruppen has also completed the sale of its rectification facility in Hamar, Norway. Together these divestments are expected to generate a capital gain of approximately NOK 7m for Arcus Gruppen and a liquidity contribution of approximately NOK 140m. The sales should be viewed in the light of Arcus Gruppen's strategy to focus on the manufacture, marketing and distribution of the group's strong brands in the Nordic wine and spirits market. Among the company's better-known brands are Linie Aquavit, Braastad Cognac and Vikingfjord Vodka. For further information, please contact:Leif Johansson, Senior Investment Manager Ratos, +46-8-700 17 00Jan Tore Føsund, CEO, Arcus Gruppen, +47-22 97 55 00Anna-Karin Celsing, Head of Corporate Communications, Ratos, +46-70-399 62 39 Financial calendar from Ratos:Year-end report 200622 February 2007Annual General Meeting11 April 2007Interim report January-March9 May 2007Interim report January-June21 August 2007Interim report January-September 9 November 2007 Ratos is a listed private equity company. The business concept is to maximise shareholder value over time by investing in, developing and divesting primarily unlisted companies. Ratos thus offers stock market players a unique investment opportunity. The equity of Ratos's investments is approximately SEK 9 billion. Ratos's holdings include Alimak Hek, Arcus, Anticimex, Bisnode, Bluegarden, Camfil, DIAB, GS-Hydro, Haendig, Haglöfs, HL Display, Hägglunds Drives, Inwido, Jøtul, Lindab, Medifiq Healthcare, Superfos and Other holdings.Attachment: Press release (PDF)Text version / Internet version / Print / Close




                                            

                

            

        

    

    



    

        
 Subscribe